Bimetallic Peroxide Nanocomposites‐Driven Redox Dyshomeostasis to Activate Sequential Cuproptosis and Pyroptosis for Amplified Tumor Immunotherapy
Advanced Science · 2026
DOI: 10.1002/advs.202512470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Guanting He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin E…. Hauptthemen laut MEDLINE: Nanocomposites, Pyroptosis, Immunotherapy, Copper. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Youth Talent Program, Heilongjiang Natural Science Foundation Project of Outstanding Youth Project, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Although metal peroxides are extensively employed in tumor therapy, novel synergistic tumor treatment approaches based on the combination of multiple types of metal peroxides are still lacking and warrant further exploration. To overcome this challenge, hyaluronic acid (HA)‐modified bimetallic peroxide nanocomposites (MgO 2 ‐CuO 2 @HA NCs) are developed by combining magnesium peroxide (MgO 2 ) nanosheets and short‐grained copper peroxide (CuO 2 ) nanodots. By modifying HA to enhance tumor targeting and stability, MgO 2 ‐CuO 2 @HA NCs leverage pH‐dependent decomposition to release Mg 2+ , H 2 O 2 , and Cu 2+ under acidic conditions, thereby initiating Fenton‐like reactions for the generation of hydroxyl radicals (•OH), while simultaneously depleting glutathione to generate Cu + . This process induces cuproptosis through the Cu + ‐mediated oligoaggregation of dihydrolipoamide S‐acetyltransferase. Additionally, enhanced •OH activates pyroptosis via the caspase‐1/gasdermin D pathway. Cuproptosis and pyroptosis can induce immunogenic cell death, thereby triggering the anti‐tumor immune responses. Notably, released Mg 2+ can enhance the activation of CD8 + T cells by promoting the conformational activation of leukocyte function‐associated antigen 1. Therefore, this study establishes a novel paradigm for synergistic anti‐tumor immunotherapy based on bimetallic peroxide nanocomposites, offering promising prospects for clinical immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
- Cancer Institute, Affiliated Tumor Hospital of Nantong University, Nantong, 226631, P. R. China.
- Department of Chemistry, The University of Hong Kong, Pokfulam, Hong Kong (SAR), 999077, China.
ORCID-Profile: Piaoping Yang
Förderung
- National Youth Talent Program, Heilongjiang Natural Science Foundation Project of Outstanding Youth Project
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Heilongjiang Provincial Postdoctoral Science Foundation
Zitieren
APA
He, G., Zhu, H., Kang, P., Feng, L., Yu, C., Zhu, Y., Liu, B., Guo, Z., & Yang, P. (2026). Bimetallic Peroxide Nanocomposites‐Driven Redox Dyshomeostasis to Activate Sequential Cuproptosis and Pyroptosis for Amplified Tumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202512470
Vancouver
He G, Zhu H, Kang P, Feng L, Yu C, Zhu Y, et al. Bimetallic Peroxide Nanocomposites‐Driven Redox Dyshomeostasis to Activate Sequential Cuproptosis and Pyroptosis for Amplified Tumor Immunotherapy. Advanced Science. 2026. doi:10.1002/advs.202512470
BibTeX
@article{He2026,
author = {He, Guanting and Zhu, Haixia and Kang, Peipei and Feng, Lili and Yu, Chenghao and Zhu, Yanlin and Liu, Bin and Guo, Zhengxiao and Yang, Piaoping},
title = {Bimetallic Peroxide Nanocomposites‐Driven Redox Dyshomeostasis to Activate Sequential Cuproptosis and Pyroptosis for Amplified Tumor Immunotherapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202512470}
}
EUVIMED